テレファーマシー市場の2030年までの予測：サービス別、提供モード別、デバイス別、エンドユーザー別、地域別の世界分析

Stratistics MRCによると、テレファーマシーの世界市場は2023年に92億米ドルを占め、予測期間中のCAGRは18.4％で成長し、2030年には301億米ドルに達する見込みです。

テレファーマシーは、通信やデジタルプラットフォームを通じて提供される遠隔医薬品サービスを包含します。薬剤師が遠隔で投薬相談、治療管理、調剤を行うことを可能にします。テレファーマシーは、特にサービスが行き届いていない地域における薬局サービスへのアクセシビリティを高め、服薬アドヒアランスを促進し、バーチャルコンサルテーションを提供することで、遠隔地との交流や技術的ソリューションを通じて患者のケアや服薬支援を支援します。

米国国立衛生研究所（NIH）の調査によると、COVID-19パンデミックの際、薬局に直接出向く場合と遠隔薬物療法を採用する場合の患者の考え方や嗜好について、回答者の約77％が遠隔薬物療法による予約を希望しています。

遠隔ヘルスケアソリューションへの需要の高まり

遠隔ヘルスケアソリューションへの需要の高まりが遠隔薬局市場を牽引しています。地理的な障壁、薬局へのアクセスの制限、便利なヘルスケアオプションの必要性などの要因が、特に農村部やサービスが行き届いていない地域で、この需要に拍車をかけています。遠隔薬物療法は、投薬相談、治療管理、処方箋補充などの遠隔薬物サービスを提供することで、こうした課題に対処します。アクセスしやすくタイムリーなヘルスケアへの要望と相まって、バーチャルなやり取りへの嗜好が高まっていることから、テレファーマシーは極めて重要なソリューションとして位置付けられ、その普及と市場成長を後押ししています。

異なる管轄区域でのライセンス取得の課題

地域や州によって異なる規制やライセンス要件は、複雑なコンプライアンス手続きを要求します。複数の司法管轄区にまたがって運営される遠隔薬物療法サービスは、多くの場合、免許取得のための厳格で時間のかかるプロセスを伴う、さまざまな法的枠組みを通過しなければならないです。異なる規制を遵守する必要性は、業務を複雑化し、管理負担を増大させ、迅速な市場拡大を妨げます。管轄区域をまたがる多様な免許要件を乗りこなすというこの課題は、遠隔薬物療法サービスのシームレスな提供を妨げ、地理的な到達範囲と拡張性を制限します。

遠隔薬物療法に対する意識の高まり

遠隔薬物療法を取り巻く意識の高まりは、市場に大きなチャンスをもたらします。遠隔ヘルスケアソリューションが患者や医療提供者の間で拡大するにつれ、遠隔薬局が提供するメリット、特に十分なサービスを受けていない地域における医薬品サービスへのアクセスの向上、服薬管理の強化、医療範囲の拡大などの認識が高まっています。このような認識は、遠隔薬物療法ソリューションの受け入れと採用を促進し、患者と医療機関の双方が遠隔サービスを受け入れることを促すため、市場の成長を促進し、遠隔薬物療法イニシアチブのより広範な実施を促進します。

プライバシーとデータセキュリティのリスク

機密性の高い患者情報を遠隔で扱うことは、サイバー脅威、データ漏洩、不正アクセスに対する脆弱性を増大させる。患者の秘密を守り、厳格なプライバシー規制を遵守することが最重要課題となっています。医療データの誤った取り扱いや不正な開示は患者の信頼を損ない、法的な影響につながる可能性があるため、市場の拡大をさらに妨げます。

COVID-19の影響：

COVID-19の大流行は遠隔薬物療法ソリューションの採用を大幅に加速させました。この危機は、遠隔地からのヘルスケアアクセスの必要性を浮き彫りにし、遠隔医療や遠隔薬局サービスへの依存の増加を促しました。ロックダウン、社会的距離対策、ヘルスケア施設の制限により、患者や医療提供者は遠隔薬局プラットフォームによる遠隔診察、処方箋補充、投薬管理を受け入れるようになった。この需要の急増は、ケアの継続性を確保するという遠隔薬物療法の可能性を示し、遠隔薬物サービスへの長期的なシフトを形成しました。

予測期間中、患者カウンセリング分野が最大になる見込み

患者カウンセリング分野は、投薬管理と患者中心のケアにおいて極めて重要な役割を果たすため、テレファーマシー市場を独占すると予想されます。遠隔薬物療法は、患者に包括的な服薬指導、投薬指示、副作用管理などの権限を与え、個別カウンセリングを容易にします。ヘルスケアでは患者の関与と服薬アドヒアランスがますます重視されるようになり、特に慢性疾患や複雑な治療に対して遠隔カウンセリングサービスを提供するテレファーマシーの能力が重要になっています。オーダーメイドのカウンセリングに対するこのような需要は、患者カウンセリング分野を推進し、テレファーマシーサービスを通じて効果的な医薬品ケアを確保することの重要性を強調しています。

予測期間中にCAGRが最も高くなると予想されるのは病院分野です。

病院分野は、進化するヘルスケア力学により、テレファーマシー市場で大幅な成長が見込まれます。病院は、患者のケアを最適化し、投薬管理を合理化し、遠隔地からサービスを拡張するために、ますます遠隔薬物療法を採用しています。病院システム内に遠隔薬物療法ソリューションを統合することで、服薬アドヒアランスが強化され、特に退院患者や慢性疾患を持つ患者のバーチャル診察が容易になります。さらに、遠隔薬物療法はヘルスケアへのアクセスを強化し、再入院率を低下させ、継続的な薬物療法サポートを保証するため、病院分野は大きく拡大します。

最大のシェアを占める地域

北米は、高度なヘルスケアインフラ、技術主導のイノベーション、成熟した遠隔医療状況により、遠隔薬物療法市場で最大の市場シェアを記録すると予想されます。同地域は、遠隔薬物療法の採用を支援する強固な規制枠組みを誇っています。さらに、ヘルスケア支出の増加、高齢化人口の増加、医療アクセスの改善が遠隔医薬品サービスの需要を促進しています。確立された遠隔医療実践と広範なデジタル接続性を持つ北米は、技術力とヘルスケアの進歩を活用し、進化する患者のニーズに対応することで、遠隔薬物療法をリードする素地があります。

CAGRが最も高い地域：

アジア太平洋地域は、ヘルスケアインフラの拡大、デジタル技術の採用の増加、利用しやすいヘルスケアサービスに対する需要の高まりにより、遠隔薬物療法市場の大幅な成長が見込まれます。遠隔薬物療法は、医薬品の専門知識への便利なアクセスを提供することで、特に遠隔地における地理的障壁に対処します。さらに、この地域のハイテクに精通した人口と、効率的な医療提供システムに対するニーズの高まりが、遠隔薬学ソリューションの採用をさらに促進し、アジア太平洋地域を遠隔薬学サービスにおける有利な成長に位置づけています。

無料カスタマイズサービス：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

• 企業プロファイル
  • 追加市場プレイヤーの包括的プロファイリング（3社まで）
  • 主要企業のSWOT分析（3社まで）
• 地域セグメンテーション
  • 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
• 競合ベンチマーキング
  • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

• 概要
• ステークホルダー
• 調査範囲
• 調査手法
  • データマイニング
  • データ分析
  • データ検証
  • 調査アプローチ
• 調査ソース
  • 1次調査ソース
  • 2次調査ソース
  • 前提条件

第3章 市場動向分析

• 促進要因
• 抑制要因
• 機会
• 脅威
• エンドユーザー分析
• 新興市場
• 新型コロナウイルス感染症（COVID-19）の影響

第4章 ポーターのファイブフォース分析

• 供給企業の交渉力
• 買い手の交渉力
• 代替品の脅威
• 新規参入業者の脅威
• 競争企業間の敵対関係

第5章 世界のテレファーマシー市場：サービス別

• 薬物療法のモニタリング
• 患者カウンセリング
• 処方薬の補充承認
• 遠隔調剤
• その他のサービス

第6章 世界のテレファーマシー市場：提供モード別

• オンプレミス
• クラウドベース
• ウェブベース

第7章 世界のテレファーマシー市場：デバイス別

• コンピュータ
• スマートフォン
• タブレットとキオスク

第8章 世界のテレファーマシー市場：エンドユーザー別

• プライマリケアセンター
• 病院
• その他のエンドユーザー

第9章 世界のテレファーマシー市場：地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン
  • その他欧州
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • オーストラリア
  • ニュージーランド
  • 韓国
  • その他アジア太平洋地域
• 南米
  • アルゼンチン
  • ブラジル
  • チリ
  • その他南米
• 中東とアフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • カタール
  • 南アフリカ
  • その他中東とアフリカ

第10章 主な発展

• 契約、パートナーシップ、コラボレーション、合弁事業
• 買収と合併
• 新製品の発売
• 事業拡大
• その他の主要戦略

第11章 企業プロファイル

• Capsule Technologies
• CPS Solutions, LLC
• Digital Pharmacist Inc.
• McKesson Ventures
• Medication Review, Inc.
• Medtel Communications
• Omnicell, Inc.
• PharmaPoint
• PioneerRx
• Pipeline Healthcare
• TelePharm (Cardinal Health)
• Transaction Data Systems, Inc.
• ZipDrug

List of Tables

• Table 1 Global Telepharmacy Market Outlook, By Region (2021-2030) ($MN)
• Table 2 Global Telepharmacy Market Outlook, By Service (2021-2030) ($MN)
• Table 3 Global Telepharmacy Market Outlook, By Drug Therapy Monitoring (2021-2030) ($MN)
• Table 4 Global Telepharmacy Market Outlook, By Patient Counselling (2021-2030) ($MN)
• Table 5 Global Telepharmacy Market Outlook, By Refill Authorization for Prescription Drugs (2021-2030) ($MN)
• Table 6 Global Telepharmacy Market Outlook, By Remote Dispensing (2021-2030) ($MN)
• Table 7 Global Telepharmacy Market Outlook, By Other Services (2021-2030) ($MN)
• Table 8 Global Telepharmacy Market Outlook, By Delivery Mode (2021-2030) ($MN)
• Table 9 Global Telepharmacy Market Outlook, By On-premises (2021-2030) ($MN)
• Table 10 Global Telepharmacy Market Outlook, By Cloud-based (2021-2030) ($MN)
• Table 11 Global Telepharmacy Market Outlook, By Web-based (2021-2030) ($MN)
• Table 12 Global Telepharmacy Market Outlook, By Device (2021-2030) ($MN)
• Table 13 Global Telepharmacy Market Outlook, By Computers (2021-2030) ($MN)
• Table 14 Global Telepharmacy Market Outlook, By Smartphones (2021-2030) ($MN)
• Table 15 Global Telepharmacy Market Outlook, By Tablets and Kiosk (2021-2030) ($MN)
• Table 16 Global Telepharmacy Market Outlook, By End User (2021-2030) ($MN)
• Table 17 Global Telepharmacy Market Outlook, By Primary Care Centers (2021-2030) ($MN)
• Table 18 Global Telepharmacy Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 19 Global Telepharmacy Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 20 North America Telepharmacy Market Outlook, By Country (2021-2030) ($MN)
• Table 21 North America Telepharmacy Market Outlook, By Service (2021-2030) ($MN)
• Table 22 North America Telepharmacy Market Outlook, By Drug Therapy Monitoring (2021-2030) ($MN)
• Table 23 North America Telepharmacy Market Outlook, By Patient Counselling (2021-2030) ($MN)
• Table 24 North America Telepharmacy Market Outlook, By Refill Authorization for Prescription Drugs (2021-2030) ($MN)
• Table 25 North America Telepharmacy Market Outlook, By Remote Dispensing (2021-2030) ($MN)
• Table 26 North America Telepharmacy Market Outlook, By Other Services (2021-2030) ($MN)
• Table 27 North America Telepharmacy Market Outlook, By Delivery Mode (2021-2030) ($MN)
• Table 28 North America Telepharmacy Market Outlook, By On-premises (2021-2030) ($MN)
• Table 29 North America Telepharmacy Market Outlook, By Cloud-based (2021-2030) ($MN)
• Table 30 North America Telepharmacy Market Outlook, By Web-based (2021-2030) ($MN)
• Table 31 North America Telepharmacy Market Outlook, By Device (2021-2030) ($MN)
• Table 32 North America Telepharmacy Market Outlook, By Computers (2021-2030) ($MN)
• Table 33 North America Telepharmacy Market Outlook, By Smartphones (2021-2030) ($MN)
• Table 34 North America Telepharmacy Market Outlook, By Tablets and Kiosk (2021-2030) ($MN)
• Table 35 North America Telepharmacy Market Outlook, By End User (2021-2030) ($MN)
• Table 36 North America Telepharmacy Market Outlook, By Primary Care Centers (2021-2030) ($MN)
• Table 37 North America Telepharmacy Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 38 North America Telepharmacy Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 39 Europe Telepharmacy Market Outlook, By Country (2021-2030) ($MN)
• Table 40 Europe Telepharmacy Market Outlook, By Service (2021-2030) ($MN)
• Table 41 Europe Telepharmacy Market Outlook, By Drug Therapy Monitoring (2021-2030) ($MN)
• Table 42 Europe Telepharmacy Market Outlook, By Patient Counselling (2021-2030) ($MN)
• Table 43 Europe Telepharmacy Market Outlook, By Refill Authorization for Prescription Drugs (2021-2030) ($MN)
• Table 44 Europe Telepharmacy Market Outlook, By Remote Dispensing (2021-2030) ($MN)
• Table 45 Europe Telepharmacy Market Outlook, By Other Services (2021-2030) ($MN)
• Table 46 Europe Telepharmacy Market Outlook, By Delivery Mode (2021-2030) ($MN)
• Table 47 Europe Telepharmacy Market Outlook, By On-premises (2021-2030) ($MN)
• Table 48 Europe Telepharmacy Market Outlook, By Cloud-based (2021-2030) ($MN)
• Table 49 Europe Telepharmacy Market Outlook, By Web-based (2021-2030) ($MN)
• Table 50 Europe Telepharmacy Market Outlook, By Device (2021-2030) ($MN)
• Table 51 Europe Telepharmacy Market Outlook, By Computers (2021-2030) ($MN)
• Table 52 Europe Telepharmacy Market Outlook, By Smartphones (2021-2030) ($MN)
• Table 53 Europe Telepharmacy Market Outlook, By Tablets and Kiosk (2021-2030) ($MN)
• Table 54 Europe Telepharmacy Market Outlook, By End User (2021-2030) ($MN)
• Table 55 Europe Telepharmacy Market Outlook, By Primary Care Centers (2021-2030) ($MN)
• Table 56 Europe Telepharmacy Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 57 Europe Telepharmacy Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 58 Asia Pacific Telepharmacy Market Outlook, By Country (2021-2030) ($MN)
• Table 59 Asia Pacific Telepharmacy Market Outlook, By Service (2021-2030) ($MN)
• Table 60 Asia Pacific Telepharmacy Market Outlook, By Drug Therapy Monitoring (2021-2030) ($MN)
• Table 61 Asia Pacific Telepharmacy Market Outlook, By Patient Counselling (2021-2030) ($MN)
• Table 62 Asia Pacific Telepharmacy Market Outlook, By Refill Authorization for Prescription Drugs (2021-2030) ($MN)
• Table 63 Asia Pacific Telepharmacy Market Outlook, By Remote Dispensing (2021-2030) ($MN)
• Table 64 Asia Pacific Telepharmacy Market Outlook, By Other Services (2021-2030) ($MN)
• Table 65 Asia Pacific Telepharmacy Market Outlook, By Delivery Mode (2021-2030) ($MN)
• Table 66 Asia Pacific Telepharmacy Market Outlook, By On-premises (2021-2030) ($MN)
• Table 67 Asia Pacific Telepharmacy Market Outlook, By Cloud-based (2021-2030) ($MN)
• Table 68 Asia Pacific Telepharmacy Market Outlook, By Web-based (2021-2030) ($MN)
• Table 69 Asia Pacific Telepharmacy Market Outlook, By Device (2021-2030) ($MN)
• Table 70 Asia Pacific Telepharmacy Market Outlook, By Computers (2021-2030) ($MN)
• Table 71 Asia Pacific Telepharmacy Market Outlook, By Smartphones (2021-2030) ($MN)
• Table 72 Asia Pacific Telepharmacy Market Outlook, By Tablets and Kiosk (2021-2030) ($MN)
• Table 73 Asia Pacific Telepharmacy Market Outlook, By End User (2021-2030) ($MN)
• Table 74 Asia Pacific Telepharmacy Market Outlook, By Primary Care Centers (2021-2030) ($MN)
• Table 75 Asia Pacific Telepharmacy Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 76 Asia Pacific Telepharmacy Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 77 South America Telepharmacy Market Outlook, By Country (2021-2030) ($MN)
• Table 78 South America Telepharmacy Market Outlook, By Service (2021-2030) ($MN)
• Table 79 South America Telepharmacy Market Outlook, By Drug Therapy Monitoring (2021-2030) ($MN)
• Table 80 South America Telepharmacy Market Outlook, By Patient Counselling (2021-2030) ($MN)
• Table 81 South America Telepharmacy Market Outlook, By Refill Authorization for Prescription Drugs (2021-2030) ($MN)
• Table 82 South America Telepharmacy Market Outlook, By Remote Dispensing (2021-2030) ($MN)
• Table 83 South America Telepharmacy Market Outlook, By Other Services (2021-2030) ($MN)
• Table 84 South America Telepharmacy Market Outlook, By Delivery Mode (2021-2030) ($MN)
• Table 85 South America Telepharmacy Market Outlook, By On-premises (2021-2030) ($MN)
• Table 86 South America Telepharmacy Market Outlook, By Cloud-based (2021-2030) ($MN)
• Table 87 South America Telepharmacy Market Outlook, By Web-based (2021-2030) ($MN)
• Table 88 South America Telepharmacy Market Outlook, By Device (2021-2030) ($MN)
• Table 89 South America Telepharmacy Market Outlook, By Computers (2021-2030) ($MN)
• Table 90 South America Telepharmacy Market Outlook, By Smartphones (2021-2030) ($MN)
• Table 91 South America Telepharmacy Market Outlook, By Tablets and Kiosk (2021-2030) ($MN)
• Table 92 South America Telepharmacy Market Outlook, By End User (2021-2030) ($MN)
• Table 93 South America Telepharmacy Market Outlook, By Primary Care Centers (2021-2030) ($MN)
• Table 94 South America Telepharmacy Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 95 South America Telepharmacy Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 96 Middle East & Africa Telepharmacy Market Outlook, By Country (2021-2030) ($MN)
• Table 97 Middle East & Africa Telepharmacy Market Outlook, By Service (2021-2030) ($MN)
• Table 98 Middle East & Africa Telepharmacy Market Outlook, By Drug Therapy Monitoring (2021-2030) ($MN)
• Table 99 Middle East & Africa Telepharmacy Market Outlook, By Patient Counselling (2021-2030) ($MN)
• Table 100 Middle East & Africa Telepharmacy Market Outlook, By Refill Authorization for Prescription Drugs (2021-2030) ($MN)
• Table 101 Middle East & Africa Telepharmacy Market Outlook, By Remote Dispensing (2021-2030) ($MN)
• Table 102 Middle East & Africa Telepharmacy Market Outlook, By Other Services (2021-2030) ($MN)
• Table 103 Middle East & Africa Telepharmacy Market Outlook, By Delivery Mode (2021-2030) ($MN)
• Table 104 Middle East & Africa Telepharmacy Market Outlook, By On-premises (2021-2030) ($MN)
• Table 105 Middle East & Africa Telepharmacy Market Outlook, By Cloud-based (2021-2030) ($MN)
• Table 106 Middle East & Africa Telepharmacy Market Outlook, By Web-based (2021-2030) ($MN)
• Table 107 Middle East & Africa Telepharmacy Market Outlook, By Device (2021-2030) ($MN)
• Table 108 Middle East & Africa Telepharmacy Market Outlook, By Computers (2021-2030) ($MN)
• Table 109 Middle East & Africa Telepharmacy Market Outlook, By Smartphones (2021-2030) ($MN)
• Table 110 Middle East & Africa Telepharmacy Market Outlook, By Tablets and Kiosk (2021-2030) ($MN)
• Table 111 Middle East & Africa Telepharmacy Market Outlook, By End User (2021-2030) ($MN)
• Table 112 Middle East & Africa Telepharmacy Market Outlook, By Primary Care Centers (2021-2030) ($MN)
• Table 113 Middle East & Africa Telepharmacy Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 114 Middle East & Africa Telepharmacy Market Outlook, By Other End Users (2021-2030) ($MN)

According to Stratistics MRC, the Global Telepharmacy Market is accounted for $9.2 billion in 2023 and is expected to reach $30.1 billion by 2030 growing at a CAGR of 18.4% during the forecast period. Telepharmacy encompasses remote pharmaceutical services delivered via telecommunications and digital platforms. It enables pharmacists to provide medication consultations, therapy management and dispensing remotely. Telepharmacy enhances accessibility to pharmacy services, especially in underserved regions, facilitates medication adherence, and offers virtual consultations, aiding in patient care and medication support through remote interactions and technological solutions.

According to the National Institute of Health (NIH) survey on patients' perspectives and preferences in adopting telepharmacy versus in-person visits to the pharmacy during the COVID-19 pandemic, about 77% of respondents preferred appointments via telepharmacy.

Market Dynamics:

Driver:

Growing demand for remote healthcare solutions

The increasing demand for remote healthcare solutions drives the telepharmacy market. Factors such as geographic barriers, limited access to pharmacies and the need for convenient healthcare options, especially in rural or underserved areas, fuel this demand. Telepharmacy addresses these challenges by offering remote pharmaceutical services, including medication consultations, therapy management, and prescription refills. The growing preference for virtual interactions, coupled with the desire for accessible and timely healthcare, positions telepharmacy as a pivotal solution, propelling its adoption and market growth.

Restraint:

Challenges in obtaining licenses across different jurisdictions

Different regulations and licensing requirements in different regions or states demand complex compliance procedures. Telepharmacy services operating across multiple jurisdictions must navigate varied legal frameworks, which often involve rigorous and time-consuming processes for licensure. The need for adherence to distinct regulations complicates operations, increases administrative burdens, and hampers swift market expansion. This challenge of navigating diverse licensing requirements across jurisdictions impedes the seamless delivery of telepharmacy services, limiting geographic reach and scalability.

Opportunity:

Growing awareness regarding the telepharmacy

The increasing awareness surrounding telepharmacy presents a significant opportunity in the market. As remote healthcare solutions grow among patients and healthcare providers, there's heightened recognition of the benefits telepharmacy offers, including improved accessibility to pharmaceutical services, enhanced medication management and expanded healthcare reach, especially in underserved areas. This awareness fosters greater acceptance and adoption of telepharmacy solutions, encouraging both patients and healthcare organizations to embrace these remote services, thereby driving the market's growth and facilitating a more widespread implementation of telepharmacy initiatives.

Threat:

Privacy and data security risks

Handling sensitive patient information remotely increases vulnerability to cyber threats, data breaches and unauthorized access. Protecting patient confidentiality and complying with stringent privacy regulations have become paramount. Mishandling or unauthorized disclosure of health data erodes patient trust and could lead to legal repercussions, which further hinders market expansion.

COVID-19 Impact:

The COVID-19 pandemic significantly accelerated the adoption of telepharmacy solutions. The crisis highlighted the need for remote healthcare access, prompting increased reliance on telemedicine and telepharmacy services. Lockdowns, social distancing measures and healthcare facility limitations pushed patients and providers to embrace remote consultations, prescription refills and medication management through telepharmacy platforms. This surge in demand showcased telepharmacy's potential in ensuring continuity of care, shaping a long-term shift towards remote pharmaceutical services.

The patient counselling segment is expected to be the largest during the forecast period

The patient counselling segment is expected to dominate the telepharmacy market due to its pivotal role in medication management and patient-centric care. Telepharmacy facilitates personalized counseling, empowering patients with comprehensive medication guidance, dosage instructions, and adverse effects management. As healthcare increasingly focuses on patient engagement and adherence, telepharmacy's ability to offer remote counseling services, especially for chronic conditions or complex therapies, becomes crucial. This demand for tailored counseling propels the patient counselling segment, emphasizing its significance in ensuring effective pharmaceutical care through telepharmacy services.

The hospitals segment is expected to have the highest CAGR during the forecast period

The hospitals segment is anticipated to experience substantial growth in the telepharmacy market due to evolving healthcare dynamics. Hospitals increasingly adopt telepharmacy to optimize patient care, streamline medication management, and extend services remotely. The integration of telepharmacy solutions within hospital systems enhances medication adherence and facilitates virtual consultations, especially for discharged patients or those with chronic conditions. Additionally, telepharmacy augments healthcare access, reducing readmission rates and ensuring continuous medication support, positioning the hospitals segment for significant expansion.

Region with largest share:

North America is expected to register the largest market share in the telepharmacy market, owing to its advanced healthcare infrastructure, tech-driven innovation, and mature telehealth landscape. The region boasts robust regulatory frameworks supporting telepharmacy adoption. Furthermore, increased healthcare spending, a growing aging population, and the emphasis on improving healthcare access drive the demand for remote pharmaceutical services. With established telehealth practices and widespread digital connectivity, North America is primed to lead in telepharmacy, leveraging its technological prowess and healthcare advancements to cater to evolving patient needs.

Region with highest CAGR:

Asia Pacific is set to witness substantial growth in the telepharmacy market due to the region's expanding healthcare infrastructure, increasing adoption of digital technology and rising demand for accessible healthcare services. Telepharmacy addresses geographical barriers, especially in remote areas, by offering convenient access to pharmaceutical expertise. Moreover, the region's tech-savvy population and the escalating need for efficient healthcare delivery systems further propel the adoption of telepharmacy solutions, positioning Asia Pacific for lucrative growth in remote pharmaceutical services.

Key players in the market:

Some of the key players in telepharmacy market include Capsule Technologies, CPS Solutions, LLC, Digital Pharmacist Inc., McKesson Ventures, Medication Review, Inc., Medtel Communications, Omnicell, Inc., PharmaPoint, PioneerRx, Pipeline Healthcare, TelePharm (Cardinal Health), Transaction Data Systems, Inc. and ZipDrug.

Key Developments:

In May 2023, OneroRx is pleased to announce that Community Pharmacy of Dunlap is open to serve residents of Dunlap, Iowa, and its surrounding communities. Community Pharmacy has worked closely with Dunlap Community Development Corporation (DCDC) to bring pharmacy services back to the area.

In July 2022, RxLive, a provider of population health pharmacy solutions, today announced a $5 million Series A funding round. The digital health startup's round was led by SpringTide, a healthtech-focused venture capital firm, with participation by Cardinal Health™, a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions in health care. RxLive has raised a total of $8 million to date.

Services Covered:

• Drug Therapy Monitoring
• Patient Counselling
• Refill Authorization for Prescription Drugs
• Remote Dispensing
• Other Services

Delivery Modes Covered:

• On-premises
• Cloud-based
• Web-based

Devices Covered:

• Computers
• Smartphones
• Tablets and Kiosk

End Users Covered:

• Primary Care Centers
• Hospitals
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 End User Analysis
• 3.7 Emerging Markets
• 3.8 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Telepharmacy Market, By Service

• 5.1 Introduction
• 5.2 Drug Therapy Monitoring
• 5.3 Patient Counselling
• 5.4 Refill Authorization for Prescription Drugs
• 5.5 Remote Dispensing
• 5.6 Other Services

6 Global Telepharmacy Market, By Delivery Mode

• 6.1 Introduction
• 6.2 On-premises
• 6.3 Cloud-based
• 6.4 Web-based

7 Global Telepharmacy Market, By Device

• 7.1 Introduction
• 7.2 Computers
• 7.3 Smartphones
• 7.4 Tablets and Kiosk

8 Global Telepharmacy Market, By End User

• 8.1 Introduction
• 8.2 Primary Care Centers
• 8.3 Hospitals
• 8.4 Other End Users

9 Global Telepharmacy Market, By Geography

• 9.1 Introduction
• 9.2 North America
  • 9.2.1 US
  • 9.2.2 Canada
  • 9.2.3 Mexico
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 Italy
  • 9.3.4 France
  • 9.3.5 Spain
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 New Zealand
  • 9.4.6 South Korea
  • 9.4.7 Rest of Asia Pacific
• 9.5 South America
  • 9.5.1 Argentina
  • 9.5.2 Brazil
  • 9.5.3 Chile
  • 9.5.4 Rest of South America
• 9.6 Middle East & Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 UAE
  • 9.6.3 Qatar
  • 9.6.4 South Africa
  • 9.6.5 Rest of Middle East & Africa

10 Key Developments

• 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 10.2 Acquisitions & Mergers
• 10.3 New Product Launch
• 10.4 Expansions
• 10.5 Other Key Strategies

11 Company Profiling

11.1 Capsule Technologies

11.2 CPS Solutions, LLC

11.3 Digital Pharmacist Inc.

11.4 McKesson Ventures

11.5 Medication Review, Inc.

11.6 Medtel Communications

11.7 Omnicell, Inc.

11.8 PharmaPoint

11.9 PioneerRx

11.10 Pipeline Healthcare

11.11 TelePharm (Cardinal Health)

11.12 Transaction Data Systems, Inc.

11.13 ZipDrug